6 active trials 2 recruiting 3 Phase 3 4 disease areas
| Phase 2 | 1 | |
| Phase 2/3 | 1 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT03731442 | Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery… | Esophageal Cancer | Recruiting | 2018-12-12 |
| NCT04762459 | Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant… | Non-small Cell Lung Carcinoma | Enrolling by Invitation | 2022-02-24 |
| Phase 2/3 | ||||
| NCT05484024 | Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally… | Rectal Neoplasms Malignant | Not Yet Recruiting | 2022-08-02 |
| Phase 2 | ||||
| NCT04437160 | Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease… | Triple Negative Breast Cancer | Recruiting | 2020-06-18 |
| Not applicable | ||||
| NCT05287308 | Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study | Breast Cancer | Not Yet Recruiting | 2022-03-31 |
| Not specified | ||||
| NCT04491721 | Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated… | Diffuse Large B Cell Lymphoma | Enrolling by Invitation | 2020-07-29 |
Breast Cancer (2) · Esophageal Cancer (1) · Triple-Negative Breast Cancer (1) · Lung Cancer (1)